BIOMAT Database Logo BIOMAT Database Logo

Methyldopa and haemolytic anaemia. 1966

K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000743 Anemia, Hemolytic A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). Anemia, Hemolytic, Acquired,Anemia, Microangiopathic,Haemolytic Anaemia,Hemolytic Anemia,Hemolytic Anemia, Acquired,Microangiopathic Hemolytic Anemia,Acquired Hemolytic Anemia,Anaemia, Haemolytic,Anemia, Acquired Hemolytic,Anemia, Microangiopathic Hemolytic,Haemolytic Anaemias,Hemolytic Anemia, Microangiopathic,Microangiopathic Anemia,Microangiopathic Hemolytic Anemias

Related Publications

K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and haemolytic anaemia.
July 1967, The Medical journal of Australia,
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and haemolytic anaemia.
January 1966, Lancet (London, England),
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and haemolytic anaemia.
February 1966, Lancet (London, England),
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and haemolytic anaemia.
February 1966, Lancet (London, England),
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and haemolytic anaemia.
June 1966, Lancet (London, England),
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and haemolytic anaemia.
May 1966, Lancet (London, England),
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Alpha methyldopa and haemolytic anaemia.
February 1973, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa and acquired haemolytic anaemia.
October 1966, The Medical journal of Australia,
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Methyldopa-induced autoimmune haemolytic anaemia revisited.
August 2009, The New Zealand medical journal,
K Carstairs, and S Worlledge, and C T Dollery, and A Breckenridge
Coombs positive haemolytic anaemia due to methyldopa.
January 1981, The British journal of clinical practice,
Copied contents to your clipboard!